Please login to the form below

Not currently logged in
Email:
Password:

Vifor Pharma appoints Dario Eklund

He takes on the role of head of international business operations

edit-Dario-EklundVifor Pharma has named Dario Eklund as their head of international business operations.

Eklund joins from Organogenesis, a regenerative medicine company which focuses in wound healing and soft tissue regeneration, where he was VP with responsibility for non-US operations, business development and licensing and the Gintuit business unit.

Prior to that, he was general manager of Switzerland for Aventis Pharma, until its 2004 merger with Sanofi, and earlier in his career he held a number of commercial and management roles for Novartis.

Eklund will report directly to Vifor Pharma CEO Søren Tulstrup and will be based at company's headquarters in Zurich, Switzerland.

Meanwhile, Vifor has also appointed Abdul Mullick to the position of head of global marketing. His previous roles include VP and general manager of endocrinology and cardiology in the rare diseases division of Sanofi in Boston, where he led the US and international operations.

18th September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics